Sigworth Stephen K
Mount Sinai School of Medicine, New York, NY, USA.
Mt Sinai J Med. 2008 Oct;75(5):442-8. doi: 10.1002/msj.20073.
Carefully managing patients undergoing elective surgeries is difficult in the perioperative setting. However, this becomes increasingly complex in patients hospitalized for acute conditions that may or may not be related to the pending surgery. Not only must the consulting physician take into consideration any complications inherent to the surgical procedure, but must also consider all related comorbidities of the acute condition for which the patient was initially hospitalized plus any existing chronic conditions. A careful systematic approach should be undertaken in these circumstances, which consists of (1) perioperative risk stratification, (2) medical optimization, and (3) perioperative risk reduction. Risk stratification is determined by the patient's inherent perioperative cardiac risk factors, whereas medical optimization and risk reduction are actively determined during the hospital course. For perioperative risk stratification, the Revised Cardiac Risk Index is the simplest tool for accurately identifying those patients at increased perioperative risk for cardiac mortality and morbidity. Medical optimization involves performing any necessary preoperative testing that would help identify concurrent undiagnosed medical conditions that might require preoperative intervention or the initiation of certain medication regimens to optimize disease treatment. Lastly, perioperative risk reduction includes any modalities that would be started to decrease the risk of potential perioperative cardiac, pulmonary, or other surgery-related comorbidities.
在围手术期,谨慎管理接受择期手术的患者颇具难度。然而,对于因急性病症住院且病症可能与待行手术相关或无关的患者而言,情况会变得愈发复杂。会诊医生不仅必须考虑手术过程中固有的任何并发症,还必须考虑患者最初因急性病症住院所伴发的所有相关合并症以及任何现有的慢性病。在这些情况下,应采取一种谨慎的系统方法,该方法包括:(1)围手术期风险分层;(2)医疗优化;(3)围手术期风险降低。风险分层由患者固有的围手术期心脏危险因素决定,而医疗优化和风险降低则在住院期间积极确定。对于围手术期风险分层,修订后的心脏风险指数是准确识别那些围手术期心脏死亡率和发病率风险增加患者的最简单工具。医疗优化包括进行任何必要的术前检查,这有助于识别可能需要术前干预或启动某些药物治疗方案以优化疾病治疗的同时存在的未确诊病症。最后,围手术期风险降低包括启动任何可降低潜在围手术期心脏、肺部或其他手术相关合并症风险的措施。